Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

793
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
793
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

2.7K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

2.9K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.

BioMed research international·2026
Same author

Nanocarriers for lung health: ameliorating inflammation and cell aging using flavonoid-based nano nutrients.

Immunopharmacology and immunotoxicology·2026
Same author

CYFRA 21-1 as a circulating biomarker in non-small cell lung cancer.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Sex and the Developmental Environment Shape Molecular Networks Underlying Bronchial Responsiveness in Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer's and Parkinson's disease.

Molecular and cellular biochemistry·2025
Same author

Extracellular vesicles in pulmonary diseases: roles and therapeutic potential.

BMC pulmonary medicine·2025
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

12.0K

How harmless are E-cigarettes? Effects in the pulmonary system.

Jack Bozier1, Razia Zakarya, David Geoffrey Chapman

  • 1Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research Respiratory Cellular and Molecular Biology Group, School of Life Sciences University of Technology Sydney Translational Airways Group, School of Life Sciences, University of Technology Sydney Airway Physiology & Imaging Group and Emphysema Centre, Woolcock Institute of Medical Research, Sydney, Australia.

Current Opinion in Pulmonary Medicine
|October 26, 2019
PubMed
Summary
This summary is machine-generated.

Electronic cigarette use is increasing globally, particularly among young adults. Research indicates vaping is not harmless and requires further study, especially concerning never-smokers and potential lung injury risks.

More Related Videos

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.3K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.8K

Related Experiment Videos

Last Updated: Jan 5, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

12.0K
Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.3K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.8K

Area of Science:

  • Pulmonology
  • Public Health
  • Nicotine Addiction

Background:

  • Electronic cigarettes (e-cigarettes) are a leading alternative nicotine source to traditional tobacco products.
  • The rapid evolution and novelty of e-cigarette devices and liquids present challenges for research and regulation.
  • Long-term epidemiological data on e-cigarette usage patterns and demographics is limited but emerging.

Purpose of the Study:

  • To review current knowledge on the pulmonary effects of e-cigarette use.
  • To summarize global patterns of e-cigarette usage.
  • To assess the implications of e-cigarette use, particularly among young adults and never-smokers.

Main Methods:

  • Literature review of existing epidemiological studies and cohort research.
  • Analysis of usage patterns and demographics across different regulatory environments.
  • Examination of reported cases of lung injury associated with vaping.

Main Results:

  • E-cigarette use is rising among young adults in the US and Canada, influenced by regulation, but not in the UK.
  • A surge in vaping-associated pulmonary injury cases has been observed, with unknown causes.
  • A significant proportion of e-cigarette users are never-smokers, challenging a sole harm reduction perspective.

Conclusions:

  • Electronic cigarettes can no longer be considered harmless.
  • Further research is crucial to understand the risks across diverse populations, including never-smokers.
  • Regulatory frameworks must consider the uptake of e-cigarettes by non-smokers in risk assessments.